Provided are methods and compositions for treating hepatitis virus
infections in mammals, especially humans. The methods comprise (1)
administering N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds in
combination with nucleoside antiviral agents, nucleotide antiviral agents,
mixtures thereof, or immunomodulating/immunostimulating agents, or (2)
administering N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds in
combination with nucleoside antivirals agents, nucleotide antiviral
agents, or mixtures thereof, and immunomodulating/immunostimulating
agents.
Desde que são os métodos e as composições para infecções de tratamento do vírus do hepatitis nos mamíferos, especial seres humanos. Os métodos compreendem (1) administrando compostos de N-substituted-1,5-dideoxy-1,5-imino-D-glucitol em combinação com agentes antiviral do nucleoside, agentes do nucleotide, misturas disso, ou agentes antiviral de immunomodulating/immunostimulating, ou (2) administrando compostos de N-substituted-1,5-dideoxy-1,5-imino-D-glucitol em combinação com agentes dos antivirals do nucleoside, agentes antiviral do nucleotide, ou misturas disso, e agentes de immunomodulating/immunostimulating.
